SCHEMBL5031601

SCHEMBL5031601

NC(=O)Nc1cc(C(F)(F)F)cc[n+]1[O-]

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.44
NR3C2 P08235 2/20 0.39
ALDH1A1 P00352 3/20 0.38
CFTR P13569 1/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TP53 P04637 1/20 0.37
TACR1 P25103 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PCTP Q9UKL6 1/20 0.36
RAB9A P51151 1/20 0.36
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2635687 0.86 TACR1 (0.42) ALDH1A1MAPTHTTLMNAMEN1
SCHEMBL10278822 0.77 CFTR (0.36) KIF11ALDH1A1CFTRMAPTLMNA
SCHEMBL90894 0.76 ALDH1A1 (0.44) ALDH1A1MAPTHTTLMNAMEN1
SCHEMBL90891 0.74 CYP11B1 (0.42) MAPTLMNAMEN1KMT2A
SCHEMBL16505901 0.73 CFTR (0.49) ALDH1A1CFTRMAPTLMNAMEN1
SCHEMBL4901404 0.73 KIF11 (0.45) KIF11ALDH1A1CFTRMAPTHTT
SCHEMBL30021484 0.73 CFTR (0.49) ALDH1A1CFTRMAPTLMNAMEN1
SCHEMBL2635688 0.70 MEN1 (0.38) KIF11ALDH1A1MAPTHTTLMNA
SCHEMBL4331680 0.69 KIF11 (0.34) KIF11ALDH1A1MAPTTACR1
SCHEMBL28141674 0.68 TAS2R14 (0.57) KIF11ALDH1A1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957485-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Healthcare, LLC (US) 2008-08-20 EP claimed
WO-2007064931-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2007-06-07 WO claimed
EP-1957485-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Healthcare, LLC (US) 2008-08-20 EP disclosed
WO-2007064931-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2007-06-07 WO disclosed